FIA
OCEA

FNY Investment Advisers’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

FNY Investment Advisers’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
600
– – ﹤0.01% 1102
2026
Q1 		$0 Hold
600
– – ﹤0.01% 1182
2025
Q4 		$0 Hold
600
– – ﹤0.01% 1622
2025
Q3 		$0 Hold
600
– – ﹤0.01% 1588
2025
Q2 		$0 Hold
600
– – ﹤0.01% 1236
2025
Q1 		$0 Hold
600
– – ﹤0.01% 1047
2024
Q4 		$0 Hold
600
– – ﹤0.01% 985
2024
Q3 		$0 Sell
600
-200
-25% -$214 ﹤0.01% 850
2024
Q2 		$0 Buy
800
+200
+33% +$341 ﹤0.01% 869
2024
Q1 		$2 Buy
+600
New +$1.13K ﹤0.01% 606

FNY Investment Advisers's OCEA Position: Q2 2026 in Review

FNY Investment Advisers held its Ocean Biomedical, Inc. Common Stock (OCEA) position steady in Q2 2026 at 600 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

FNY Investment Advisers first reported a position in OCEA in Q1 2024 and has held it in 10 quarters since. The position peaked at $2 in Q1 2024. 1 fund tracked by Wall St. Rank holds OCEA as of Q2 2026.

  • FNY Investment Advisers held 600 shares of Ocean Biomedical, Inc. Common Stock worth $0 as of Q2 2026.
  • FNY Investment Advisers left its Ocean Biomedical, Inc. Common Stock share count unchanged in Q2 2026.
  • Ocean Biomedical, Inc. Common Stock made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #1102 holding.
  • FNY Investment Advisers first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2024 and has held it in 10 quarters since.
  • FNY Investment Advisers's Ocean Biomedical, Inc. Common Stock position peaked at $2 in Q1 2024.
  • 1 fund tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.